FRANK J. WILLIAMS - 02 Mar 2022 Form 4 Insider Report for Evolent Health, Inc. (EVH)

Role
Director
Signature
/s/ Jonathan Weinberg, Attorney-in-fact
Issuer symbol
EVH
Transactions as of
02 Mar 2022
Net transactions value
-$5,220,703
Form type
4
Filing time
10 Mar 2022, 19:27:10 UTC
Previous filing
18 Feb 2022
Next filing
13 Jun 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EVH Class A Common Stock Options Exercise $0 +382,489 +69% $0.000000 940,298 02 Mar 2022 Direct F1, F2
transaction EVH Class A Common Stock Tax liability $5,220,703 -189,568 -20% $27.54 750,730 03 Mar 2022 Direct F2, F3
holding EVH Class A Common Stock 66,064 02 Mar 2022 See footnote F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EVH Leveraged Restricted Stock Unit Options Exercise $0 -382,489 -100% $0.000000* 0 02 Mar 2022 Class A Common Stock 382,489 $0.000000 Direct F5, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the vesting of the leveraged stock units granted to Mr. Williams on March 1, 2019, based on the cumulative performance of the Issuer's Class A Common Stock.
F2 Includes restricted stock units granted under awards reported on Table I of Form 4s previously filed with the Securities and Exchange Commission.
F3 This number represents shares of Class A Common Stock withheld to satisfy the tax withholding obligation due upon vesting of leveraged stock units.
F4 Shares held of record by the Frank Williams Irrevocable Trust. Mr. Williams serves as the Trustee of the Frank Williams Irrevocable Trust.
F5 Leveraged Stock Units vested on March 2, 2022.
F6 These Leveraged Stock Units do not expire.